Advertisement

Evaluation of the Immune Response After Administration of Plasmid DNA-Non-viral Vector Complexes

Chapter
  • 992 Downloads

Keywords

Gene Delivery Vector Complex Cationic Lipid Gene Delivery System Cytokine Induction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ahmad-Nejad P, Hacker H, et al. (2002) Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur J Immunol 32:1958–1968CrossRefPubMedGoogle Scholar
  2. Dow SW, Elmslie RE, et al. (1999) Intravenous cytokine gene delivery by lipid-DNA complexes controls the growth of established lung metastases. Hum Gene Ther 10:2961–2972PubMedGoogle Scholar
  3. Dow SW, Fradkin LG, et al. (1999) Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J Immunol 163:1552–1561PubMedGoogle Scholar
  4. Gautam A, Densmore CL, et al. (2001) Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy. Gene Ther 8:254–257CrossRefPubMedGoogle Scholar
  5. Hemmi H, Kaisho T, et al. (2003) The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J Immunol 170:3059–3064PubMedGoogle Scholar
  6. Hemmi H, Takeuchi O, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408:740–745PubMedGoogle Scholar
  7. Hood JD, Bednarski M, et al. (2002) Tumor regression by targeted gene delivery to the neovasculature. Science 296:2404–2407CrossRefPubMedGoogle Scholar
  8. Li S and Huang L. (1997) In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther 4:891–900PubMedGoogle Scholar
  9. Li S, Wu SP, et al. (1999) Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors. Am J Physiol 276:L796–804PubMedGoogle Scholar
  10. Liu T, Matsuguchi T, et al. (2002) Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect Immun 70:6638–6645PubMedGoogle Scholar
  11. Lund J, Sato A, et al. (2003) Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 198:513–520CrossRefPubMedGoogle Scholar
  12. Mahato RI, Kawabata K, et al. (1995) Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. J Pharm Sci 84:1267–1271PubMedGoogle Scholar
  13. McLean JW, Fox EA, et al. (1997) Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol 273:H387–404PubMedGoogle Scholar
  14. Muruve DA, Barnes MJ, Stillman IE, Libermann TA (1999) Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther 10:965–976CrossRefPubMedGoogle Scholar
  15. Muruve DA, Cotter MJ, et al. (2004) Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo. J Virol 78:5966–5972CrossRefPubMedGoogle Scholar
  16. Nomura T, Yasuda K, et al. (1999) Gene expression and antitumor effects following direct interferon (IFN)-gamma gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice. Gene Ther 6:121–129CrossRefPubMedGoogle Scholar
  17. Osaka G, Carey K, et al. (1996) Pharmacokinetics, tissue distribution, and expression efficiency of plasmid [33P]DNA following intravenous administration of DNA/cationic lipid complexes in mice: use of a novel radionuclide approach. J Pharm Sci 85:612–618CrossRefPubMedGoogle Scholar
  18. Raper SE, Chirmule N, et al. (2003) Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80:148–158CrossRefPubMedGoogle Scholar
  19. Sakurai F, Terada T, et al. (2003) Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model. Cancer Gene Ther 10:661–668CrossRefPubMedGoogle Scholar
  20. Sakurai F, Terada T, et al. (2002) The role of tissue macrophages in the induction of proin-flammatory cytokine production following intravenous injection of lipoplexes. Gene Ther 9:1120–1126CrossRefPubMedGoogle Scholar
  21. Sivori S, Falco M, et al. (2004) CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USAGoogle Scholar
  22. Sonoda KH, Sasa Y, Qiao H, Tsutsumi C, Hisatomi T, Komiyama S, Kubota T, Sakamoto T, Kawano Y, Ishibashi T (2003) Immunoregulatory role of ocular macrophages: the macrophages produce RANTES to suppress experimental autoimmune uveitis. J Immunol 171:2652–2659PubMedGoogle Scholar
  23. Tan Y, Li S, et al. (1999) The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo. Hum Gene Ther 10:2153–2161CrossRefPubMedGoogle Scholar
  24. Todt J, Sonstein J, Polak T, Seitzman GD, Hu B, Curtis JL (2000) Repeated intratracheal challenge with particulate antigen modulates murine lung cytokines. J Immunol 164:4037–4047PubMedGoogle Scholar
  25. Tousignant JD, Gates AL, et al. (2000) Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid: plasmid DNA complexes in mice. Hum Gene Ther 11:2493–2513CrossRefPubMedGoogle Scholar
  26. Wagner M, Poeck H, et al. (2004) IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J Immunol 172:954–963PubMedGoogle Scholar
  27. Wesselingh SL, Levine B, Fox RJ, Choi S, Griffin DE (1994) Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J Immunol 152:1289–1297PubMedGoogle Scholar
  28. Whitmore M, Li S, et al. (1999) LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Ther 6:1867–1875CrossRefPubMedGoogle Scholar
  29. Yamada T, Iwasaki Y, et al. (2003) Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat Biotechnol 21:885–890CrossRefPubMedGoogle Scholar
  30. Yasuda K, Ogawa Y, et al. (2002) Plasmid DNA activates murine macrophages to induce inflammatory cytokines in a CpG motif-independent manner by complex formation with cationic liposomes. Biochem Biophys Res Commun 293:344–348CrossRefPubMedGoogle Scholar
  31. Yew NS, Zhao H, et al. (2002) CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol Ther 5:731–738CrossRefPubMedGoogle Scholar
  32. Yoshidome H, Kato A, Edwards MJ, Lentsch AB (1999) Interleukin-10 suppresses hepatic ischemia/reperfusion injury in mice: implications of a central role for nuclear factor kappaB. Hepatology 30:203–208CrossRefPubMedGoogle Scholar
  33. Zhang Y, Chirmule N, et al. (2001) Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther 3:697–707PubMedGoogle Scholar
  34. Zhao H, Hemmi H, et al. (2004) Contribution of Toll-like receptor 9 signaling to the acute inflammatory response to nonviral vectors. Mol Ther 9:241–248CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 2005

Authors and Affiliations

  1. 1.Department of Drug Delivery System, Graduate School of Pharmaceutical SciencesKyoto UniversityKyotoJapan
  2. 2.Department of Biopharmaceutics and Drug Metabolism, Graduate School of Pharmaceutical SciencesKyoto UniversityKyotoJapan

Personalised recommendations